Vascular Biogenics Ltd (VBLT)

[gr8db8]

Doing the math, I can see why Dror thinks that the number of deaths will happen before the 12-month follow up for 50% of the patients.

Avastin median OS = 32 weeks (this has been established from pooled data of prior Avastin trials)
VB-111 median OS = 59 weeks (from phase 2)

Based on the above numbers, 105 deaths out of 252 patients should happen before the 12-month/52-week follow up for 50% of the patients.

This is an educated guess from Dror/VBL. It is highly likely to play out this way but it does not mean that they know the data. They are blinded to the data.